TrialFrontiers in pharmacology2025

Pharmacokinetics and safety of the antitumor drug everolimus in healthy Chinese subjects: a single-dose, open-label, randomized, two-sequence, two-period crossover, phase I bioequivalence study.

Xiaodan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.